| abstract |
The present invention is related to a compound of the formula (I):n nor a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having 1 heteroatom, wherein said heteroatom is N, and nR 5 -R 8 ; R 17 are as defined in the claims, and their use as bradykinin B 2 receptor modulators. |